Maximus, Inc. (MMS) Stake Maintained by Icon Advisers Inc. Co.
Icon Advisers Inc. Co. maintained its stake in Maximus, Inc. (NYSE:MMS) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,500 shares of the health services provider’s stock at the end of the second quarter. Icon Advisers Inc. Co.’s holdings in Maximus were worth $1,409,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. increased its holdings in shares of Maximus by 22,491.0% in the 1st quarter. BlackRock Inc. now owns 6,503,511 shares of the health services provider’s stock valued at $404,518,000 after purchasing an additional 6,474,723 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Maximus by 8.0% in the 1st quarter. Vanguard Group Inc. now owns 5,538,187 shares of the health services provider’s stock valued at $344,476,000 after purchasing an additional 411,521 shares in the last quarter. William Blair Investment Management LLC increased its holdings in shares of Maximus by 14.7% in the 1st quarter. William Blair Investment Management LLC now owns 4,416,279 shares of the health services provider’s stock valued at $274,693,000 after purchasing an additional 566,292 shares in the last quarter. Victory Capital Management Inc. increased its holdings in shares of Maximus by 8.6% in the 2nd quarter. Victory Capital Management Inc. now owns 3,100,903 shares of the health services provider’s stock valued at $194,210,000 after purchasing an additional 244,823 shares in the last quarter. Finally, State Street Corp increased its holdings in shares of Maximus by 2.5% in the 1st quarter. State Street Corp now owns 2,066,226 shares of the health services provider’s stock valued at $128,517,000 after purchasing an additional 50,670 shares in the last quarter. Institutional investors and hedge funds own 97.23% of the company’s stock.
In other Maximus news, General Counsel David Francis sold 2,000 shares of the business’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $58.89, for a total value of $117,780.00. Following the sale, the general counsel now directly owns 13,716 shares in the company, valued at $807,735.24. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Bruce Caswell sold 8,000 shares of the business’s stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $62.21, for a total transaction of $497,680.00. Following the completion of the sale, the president now owns 35,904 shares in the company, valued at $2,233,587.84. The disclosure for this sale can be found here. Over the last quarter, insiders sold 125,403 shares of company stock worth $7,645,251. 3.10% of the stock is owned by company insiders.
Maximus, Inc. (NYSE:MMS) opened at 63.58 on Friday. Maximus, Inc. has a 12-month low of $43.69 and a 12-month high of $64.97. The firm’s 50-day moving average is $60.72 and its 200 day moving average is $61.45. The stock has a market capitalization of $4.12 billion, a P/E ratio of 20.38 and a beta of 1.37.
Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, topping the consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The firm had revenue of $600.40 million for the quarter, compared to analysts’ expectations of $614.12 million. During the same period in the previous year, the business earned $0.79 earnings per share. Maximus’s revenue for the quarter was down 2.7% compared to the same quarter last year. Equities research analysts anticipate that Maximus, Inc. will post $3.13 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th were given a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date of this dividend was Friday, August 11th. Maximus’s dividend payout ratio (DPR) is presently 5.73%.
A number of brokerages have recently issued reports on MMS. BidaskClub downgraded shares of Maximus from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Canaccord Genuity downgraded shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 price target for the company. in a report on Tuesday, July 4th. Zacks Investment Research downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Robert W. Baird reiterated a “hold” rating and issued a $64.00 price target on shares of Maximus in a report on Friday, September 1st. Finally, Maxim Group set a $66.00 price target on shares of Maximus and gave the company a “hold” rating in a report on Thursday, August 3rd. One research analyst has rated the stock with a sell rating and nine have issued a hold rating to the stock. The company has a consensus rating of “Hold” and an average price target of $62.43.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.